BCM
Bayesian Capital Management’s Novartis NVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,700
| Closed | -$1.56M | – | 941 |
|
|
2024
Q2 | $1.56M | Buy |
14,700
+4,100
| +39% | +$436K | 0.18% | 152 |
|
|
2024
Q1 | $1.03M | Buy |
+10,600
| New | +$1.03M | 0.1% | 281 |
|
|
2023
Q2 | – | Sell |
-16,793
| Closed | -$1.54M | – | 985 |
|
|
2023
Q1 | $1.54M | Sell |
16,793
-19,800
| -54% | -$1.82M | 0.19% | 157 |
|
|
2022
Q4 | $3.32M | Buy |
36,593
+9,600
| +36% | +$871K | 0.49% | 21 |
|
|
2022
Q3 | $2.05M | Buy |
+26,993
| New | +$2.05M | 0.42% | 46 |
|
|
2022
Q2 | – | Sell |
-16,617
| Closed | -$1.46M | – | 988 |
|
|
2022
Q1 | $1.46M | Buy |
+16,617
| New | +$1.46M | 0.22% | 126 |
|
|
2020
Q4 | – | Sell |
-7,213
| Closed | -$627K | – | 614 |
|
|
2020
Q3 | $627K | Buy |
+7,213
| New | +$627K | 0.15% | 176 |
|
|
2020
Q1 | – | Sell |
-6,998
| Closed | -$663K | – | 920 |
|
|
2019
Q4 | $663K | Sell |
6,998
-20,600
| -75% | -$1.95M | 0.11% | 241 |
|
|
2019
Q3 | $2.4M | Buy |
27,598
+22,300
| +421% | +$1.94M | 0.45% | 47 |
|
|
2019
Q2 | $484K | Buy |
+5,298
| New | +$484K | 0.1% | 272 |
|
|
2019
Q1 | – | Sell |
-4,500
| Closed | -$386K | – | 695 |
|
|
2018
Q4 | $386K | Buy |
+4,500
| New | +$386K | 0.08% | 346 |
|
|
2018
Q3 | – | Sell |
-10,812
| Closed | -$817K | – | 752 |
|
|
2018
Q2 | $817K | Sell |
10,812
-10,415
| -49% | -$787K | 0.18% | 148 |
|
|
2018
Q1 | $1.72M | Buy |
+21,227
| New | +$1.72M | 0.44% | 34 |
|
|
2017
Q4 | – | Sell |
-13,127
| Closed | -$1.13M | – | 670 |
|
|
2017
Q3 | $1.13M | Buy |
13,127
+9,100
| +226% | +$781K | 0.27% | 118 |
|
|
2017
Q2 | $336K | Buy |
+4,027
| New | +$336K | 0.12% | 257 |
|